Drugs / lanicemine
lanicemine
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 16 trials | ||||||
| Phase 1 | NCT03166501 | Sep 2018 → Nov 2019 | depressive disorder, post-traumatic stress disorder | Baylor College of Medicine | Completed | No outcome recorded |
| Phase 1 | NCT01130909 | May 2010 → Jan 2011 | — | AstraZeneca | Terminated | No outcome recorded |
| Phase 1 | NCT01069822 | Feb → May 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01046630 | Dec 2009 → Mar 2011 | depressive disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00963365 | Nov 2008 → Feb 2009 | — | AstraZeneca | Withdrawn | No outcome recorded |
| Phase 1 | NCT00785915 | Nov 2008 → Mar 2009 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01482221 | Dec 2011 → Aug 2013 | major depressive disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 2 | NCT00986479 | Dec 2009 → Dec 2011 | major depressive disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 2 | NCT00781742 | Oct 2008 → Mar 2010 | major depressive disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 2 | NCT00491686 | Jul → Nov 2007 | major depressive disorder | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lanicemine | “Using quantitative electroencephalography (qEEG) to objectively align doses of a low-trapping NMDA channel blocker, AZD6765 (lanicemine), to that of ketamine, we demonstrate...” PMID 24126931 ↗ Oct 20132“Intravenous infusion of lanicemine (formerly AZD6765), a low trapping non-selective N-methyl-D-aspartate (NMDA) receptor antagonist, induces antidepressant effects with a...” PMID 27133029 ↗ Apr 2016 |
| Known as | AR-R15896AR | ChEMBL registry synonym — accepted as the source's own label CHEMBL467084 ↗ |
| Known as | AZD6765 | “Intravenous infusion of lanicemine (formerly AZD6765), a low trapping non-selective N-methyl-D-aspartate (NMDA) receptor antagonist, induces antidepressant effects with a...” PMID 27133029 ↗ Apr 2016 |
| Known as | Lanicemina | ChEMBL registry synonym — accepted as the source's own label CHEMBL467084 ↗ |
| Action | Inhibit | “a low-trapping NMDA channel blocker” PMID 24126931 ↗ Oct 2013 |
| Modality | Small molecule | — CHEMBL467084 ↗ |
| Route | Intravenous | “intravenous infusion” NCT00491686 ↗ |